Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index.

BACKGROUND Although both ethanol consumption and overweight alter the activities of hepatic enzymes in circulation, the differentiation of an alcohol or nonalcohol basis for such changes remains problematic. The magnitude of alterations occurring among moderate drinkers has remained obscure. OBJECTIVE We examined the links between moderate ethanol consumption, body mass index (BMI; in kg/m(2)), and liver enzymes. DESIGN Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) were recorded from 2,164 apparently healthy participants (1,028 men, 1,136 women) reporting either no alcohol (abstainers) or <40 g ethanol consumption per day (moderate drinkers). The study population was further classified according to BMI as follows: <19 (underweight), > or =19 and <25 (normal weight), > or =25 and <30 (overweight), and > or =30 (obese). RESULTS Serum ALT (P < 0.05) and GGT (P < 0.001) but not AST (P = 0.805) activities in moderate drinkers were higher than those in abstainers. For all enzymes, a significant main effect was observed of increasing BMI, which was more striking in moderate drinkers than in abstainers. Tests of between-subjects effects indicated significant interactions with sex and drinking status, although not with sex and BMI. CONCLUSIONS The effect of moderate alcohol consumption on liver enzymes increases with increasing BMI. These findings should be considered in the clinical assessment of overweight alcohol consumers and in the definition of normal ranges for liver enzymes. These results may also help to develop new approaches for examining patients with fatty liver induced by either ethanol or adiposity.

[1]  Yoosoo Chang,et al.  Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. , 2007, Clinical chemistry.

[2]  O. Niemelä.  Biomarkers in alcoholism. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[3]  J. Sauver,et al.  Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[4]  S. Sanderson,et al.  Utility of a new model to diagnose an alcohol basis for steatohepatitis. , 2006, Gastroenterology.

[5]  G. Friedman,et al.  Coffee, cirrhosis, and transaminase enzymes. , 2006, Archives of internal medicine.

[6]  R. Bloigu,et al.  Additive effects of moderate drinking and obesity on serum γ-glutamyl transferase activity , 2006 .

[7]  Jim McCambridge,et al.  Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data , 2006, The Lancet.

[8]  R. Bloigu,et al.  Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. , 2006, The American journal of clinical nutrition.

[9]  C. Day.  From fat to inflammation. , 2006, Gastroenterology.

[10]  D. Jacobs,et al.  A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. , 2006, American journal of epidemiology.

[11]  J. Everhart,et al.  Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  S. Haffner,et al.  Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. , 2005, Diabetes.

[13]  H. Concin,et al.  γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults , 2005, Circulation.

[14]  G. Tarantino,et al.  Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy , 2005, Annals of Nutrition and Metabolism.

[15]  O. Niemelä,et al.  Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease , 2005, The American Journal of Gastroenterology.

[16]  D. Lawlor,et al.  The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. , 2005, American journal of epidemiology.

[17]  J. Rohrer,et al.  Bmc Family Practice Frequency of Alcohol Use and Obesity in Community Medicine Patients , 2022 .

[18]  R. Room,et al.  Alcohol and public health , 2005, The Lancet.

[19]  A. Cederbaum,et al.  A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[21]  A. Diehl.  Obesity and alcoholic liver disease. , 2004, Alcohol.

[22]  D. Bullard,et al.  Regulation of endothelial glutathione by ICAM‐1: implications for inflammation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  C. Lieber,et al.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.

[24]  B. Conway,et al.  Obesity as a disease: no lightweight matter , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[25]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[26]  D. Jacobs,et al.  ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress? , 2004, Free radical research.

[27]  J. Freudenheim,et al.  Body fat distribution, relative weight, and liver enzyme levels: A population‐based study , 2004, Hepatology.

[28]  A. Cederbaum,et al.  Oxidative stress, toxicology, and pharmacology of CYP2E1. , 2004, Annual review of pharmacology and toxicology.

[29]  J. Whitfield,et al.  Traditional markers of excessive alcohol use. , 2003, Addiction.

[30]  Peter Neuhaus,et al.  Sex is a major determinant of CYP3A4 expression in human liver , 2003, Hepatology.

[31]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[32]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[33]  L. Aronne,et al.  The emerging science of body weight regulation and its impact on obesity treatment. , 2003, The Journal of clinical investigation.

[34]  C. Bogardus,et al.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[35]  O. Niemelä,et al.  Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. , 2000, Journal of hepatology.

[36]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[37]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[38]  O. Niemelä,et al.  Induction of cytochrome P450 enzymes and generation of protein‐aldehyde adducts are associated with sex‐dependent sensitivity to alcohol‐induced liver disease in micropigs , 1999, Hepatology.

[39]  C. Halsted.  Obesity: effects on the liver and gastrointestinal system. , 1999, Current opinion in clinical nutrition and metabolic care.

[40]  T. Smith,et al.  Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. , 1998, Alcoholism, clinical and experimental research.

[41]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[42]  S. Schenker.  CURRENT LITERATURE REVIEWED AND CRITIQUED , 1997 .

[43]  S. Schenker.  Medical consequences of alcohol abuse: is gender a factor? , 1997, Alcoholism, clinical and experimental research.

[44]  C. Lieber.  Medical disorders of alcoholism. , 1995, The New England journal of medicine.

[45]  G. Brittenham,et al.  Experimental liver cirrhosis induced by alcohol and iron. , 1995, The Journal of clinical investigation.

[46]  M. Hodgson.  Alanine aminotransferase in clinical practice. , 1992, Archives of internal medicine.

[47]  A. Salvaggio,et al.  Body mass index and liver enzyme activity in serum. , 1991, Clinical chemistry.

[48]  K. Sherman.  Alanine aminotransferase in clinical practice. A review. , 1991, Archives of internal medicine.

[49]  F. Schaffner,et al.  Effect of weight reduction on hepatic abnormalities in overweight patients. , 1990, Gastroenterology.

[50]  Y. Israel,et al.  Role of hepatic γ‐glutamyltransferase in the degradation of circulating glutathione: Studies in the intact guinea pig perfused liver , 1990, Hepatology.